Alector | News

Johnson & Johnson, Alector team up on Alzheimer’s therapies

In a novel partnership, Janssen Pharmaceuticals said Monday it will fund San Francisco biotech startup Alector’s efforts to develop new therapies for Alzheimer’s disease. The research agreement between Alector and Janssen, the pharmaceutical arm of Johnson & Johnson, reflects a growing relationship between young biotech…